ClearBridge Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-658,396
Closed -$25.8M – 1139
2018
Q4
$25.8M Sell
658,396
-880
-0.1% -$38.2K 0.03% 392
2018
Q3
$36M Buy
659,276
+30
+0% +$2.05K 0.03% 370
2018
Q2
$54.6M Sell
659,246
-28,045
-4% -$2.16M 0.04% 304
2018
Q1
$45.8M Sell
687,291
-153
-0% -$8.84K 0.04% 321
2017
Q4
$35.3M Buy
687,444
+19,492
+3% +$1.4M 0.03% 357
2017
Q3
$59.6M Sell
667,952
-1,800
-0.3% -$137K 0.06% 286
2017
Q2
$40M Sell
669,752
-1,748
-0.3% -$97.7K 0.04% 344
2017
Q1
$35.8M Buy
671,500
+53
+0% +$3.15K 0.04% 359
2016
Q4
$33.5M Buy
671,447
+30,069
+5% +$1.61M 0.04% 341
2016
Q3
$38.5M Sell
641,378
-584
-0.1% -$33.7K 0.04% 323
2016
Q2
$32.8M Buy
641,962
+301
+0% +$12.9K 0.04% 336
2016
Q1
$18.9M Sell
641,661
-69
-0% -$2.18K 0.02% 406
2015
Q4
$29.1M Buy
641,730
+393,724
+159% +$20.6M 0.03% 360
2015
Q3
$10.3M Buy
248,006
+158
+0.1% +$8.24K 0.01% 488
2015
Q2
$14.9M Sell
247,848
-362
-0.1% -$23.9K 0.02% 462
2015
Q1
$19.2M Buy
+248,210
New +$14.3M 0.02% 431

Other funds holding ONCE

ClearBridge Investments's ONCE Position: Q1 2019 in Review

ClearBridge Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 658,396 shares — an estimated $25.8M sold.

ClearBridge Investments first reported a position in ONCE in Q1 2015 and held it in 16 quarters. The position peaked at $59.6M in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • ClearBridge Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • ClearBridge Investments sold 658,396 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $25.8M.
  • ClearBridge Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 16 quarters.
  • ClearBridge Investments's Spark Therapeutics, Inc. Common Stock position peaked at $59.6M in Q3 2017.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on ClearBridge Investments's 13F filing for Q1 2019, filed 15 May 2019.